Holbæk Sygehus

Medicin og biovidenskab

1. Denmark 100%
2. Randomized Controlled Trials 90%
3. Systematic Reviews 84%
4. Cohort Studies 82%
5. Pediatric Obesity 80%
6. Meta-Analysis 68%
7. Child 66%
8. Mortality 62%
9. Obesity 57%
10. Blood Pressure 52%
11. Population 48%
12. Confidence Intervals 45%
13. Therapeutics 40%
14. Overweight 39%
15. Osteoporosis 39%
16. Cardiovascular Diseases 38%
17. Registries 38%
18. Health 36%
19. Body Mass Index 36%
20. Type 2 Diabetes Mellitus 36%
21. Hypertension 34%
22. Hip Fractures 34%
23. Placebos 32%
24. Quality of Life 29%
25. Intensive Care Units 28%
26. Odds Ratio 28%
27. Exercise 27%
28. Diphosphonates 26%
29. Occupational Groups 24%
30. Osteoporotic Fractures 23%
31. Pregnancy 22%
32. Pain 21%
33. Observational Studies 21%
34. Serum 20%
35. Guidelines 20%
36. Myocardial Ischemia 20%
37. Critical Care 20%
38. Incidence 20%
39. Fasting 19%
40. Glucose 19%
41. Critical Illness 19%
42. Heart Failure 18%
43. Prospective Studies 18%
44. Databases 18%
45. Workplace 18%
46. Cross-Sectional Studies 17%
47. Parturition 17%
48. First Pregnancy Trimester 17%
49. Atrial Fibrillation 17%
50. Myocardial Infarction 17%
51. Uterine Rupture 17%
52. Fats 17%
53. Nurses 17%
54. Low Back Pain 17%
55. Comorbidity 16%
56. Biomarkers 16%
57. Insulin Resistance 16%
58. Weights and Measures 16%
59. Safety 16%
60. Elderly 16%
61. Vitamin D 15%
62. Hospital Emergency Service 15%
63. Morbidity 15%
64. Leisure Activities 15%
65. Cardiac Rehabilitation 15%
66. Coronavirus 15%
67. Gestational Age 14%
68. Left Ventricular Hypertrophy 14%
69. Weight Loss 14%
70. Early Warning Score 14%
71. Leptin 14%
72. Carotid-Femoral Pulse Wave Velocity 13%
73. Hospitalization 13%
74. Urokinase Plasminogen Activator Receptors 13%
75. Reference Values 13%
76. Stroke 13%
77. Receptor, Melanocortin, Type 4 12%
78. Pediatrics 12%
79. Depression 12%
80. Multicenter Studies 12%
81. Delivery of Health Care 12%
82. Renal Replacement Therapy 12%
83. Delirium 12%
84. Acetaminophen 12%
85. Antihypertensive Agents 12%
86. Bone Density 11%
87. Clinical Trials 11%
88. Case-Control Studies 11%
89. Pharmaceutical Preparations 11%
90. Thyrotropin 11%
91. Scandinavian and Nordic Countries 11%
92. Pregnancy-Associated Plasma Protein-A 11%
93. Data Analysis 11%
94. Bone and Bones 11%
95. Chronic Hepatitis B 11%